Panax notoginseng saponins potentiate osteogenesis of bone marrow stromal cells by modulating gap junction intercellular communication activities

Cellular Physiology and Biochemistry

Volumn 26, Issue 6, 2010, Pages 1081-1092

  Li, Xue Dong ^a   Chang, Bo ^a   Chen, Bin ^a   Liu, Zhao Yong ^a   Liu, Dong Xin ^a   Wang, Jian Sheng ^a   Hou, Guo Qing ^a   Huang, Dong Yang ^a   Du, Shi Xin ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Bone marrow stromal cells; Gap junction intercellular communication; Osteogenesis; Panax notoginseng saponins

Indexed keywords

18ALPHA GLYCYRRHETINIC ACID; ALIZARIN; ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; CALCIUM; CELL SURFACE MARKER; CORE BINDING FACTOR; LUCIFER YELLOW; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PANAX NOTOGINSENG EXTRACT; PANAX NOTOGINSENG SAPONIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SAPONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE LEVEL; BONE MARROW CELL; CELL COMMUNICATION; CELL JUNCTION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; GAP JUNCTION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANAX NOTOGINSENG; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STROMA CELL;

PANAX NOTOGINSENG; RATTUS;

EID: 78651226169     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323986     Document Type: Article

References (35)

1. Owen M, Friedenstein AJ: Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988;136:42-60.
2. Cancedda R, Mastrogiacomo M, Bianchi G, Derubeis A, Muraglia A, Quarto R: Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp 2003;249:133-43; discussion 43-7,70-4,239-41.
3. Derubeis AR, Cancedda R: Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng 2004;32:160-165.
4. Rodan GA: Introduction to bone biology. Bone 1992;13:S3-6.
5. Stains JP, Civitelli R: Gap junctions in skeletal development and function. Biochim Biophys Acta 2005;1719:69-81.
6. Ng TB: Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol 2006;58:1007-1019.
7. Chen W, Dang Y, Zhu C: Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study. Chin Med 2010;5:12.
8. Chen XC, Zhou YC, Chen Y, Zhu YG, Fang F, Chen LM: Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin 2005;26:56-62.
9. Rhule A, Navarro S, Smith JR, Shepherd DM: Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. J Ethnopharmacol 2006;106:121-128.
10. Gong YS, Chen J, Zhang QZ, Zhang JT: Effect of 17beta-oestradiol and ginsenoside on osteoporosis in ovariectomised rats. J Asian Nat Prod Res 2006;8:649-656.
11. Lu XZ, Wang JH, Wu X, Zhou L, Wang L, Zhang XW, Cao KJ, Huang J: Ginsenoside Rg1 promotes bone marrow stromal cells proliferation via the activation of the estrogen receptor-mediated signaling pathway. Acta Pharmacol Sin 2008;29:1209-1214.
12. Shen Y, Li YQ, Li SP, Ma L, Ding LJ, Ji H: Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. J Nat Med 2010;64:336-345.
13. Chang CH, Liao TC, Hsu YM, Fang HW, Chen CC, Lin FH: A poly(propylene fu-marate)-calcium phosphate based ang-iogenic injectable bone cement for femoral head osteonecrosis. Biomaterials 2010;31:4048-4055.
14. Zhang YW, Morita I, Zhang L, Shao G, Yao XS, Murota S: Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: Inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication. Planta Med 2000;66:119-123.
15. Zhang YW, Dou DQ, Zhang L, Chen YJ, Yao XS: Effects of ginsenosides from Panax ginseng on cell-to-cell communication function mediated by gap junctions. Planta Med 2001;67:417-422.
16. Fu L, Tang T, Miao Y, Zhang S, Qu Z, Dai K: Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone 2008;43:40-47.
17. Kamijo M,Haraguchi T,Tonogi M,Yamane GY: The function of connexin 43 on the differentiation of rat bone marrow cells in culture. Biomed Res 2006;27:289-295.
18. Gregory CA, Gunn WG, Peister A, Prockop DJ: An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004;329:77-84.
19. Yanagiya T, Tanabe A, Hotta K: Gap-junctional communication is required for mitotic clonal expansion during adipogenesis. Obesity (Silver Spring) 2007;15:572-582.
20. Civitelli R: Cell-cell communication in the osteoblast/osteocyte lineage. Arch Biochem Biophys 2008;473:188-192.
21. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
22. Manolagas SC, Jilka RL: Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-311.
23. Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S: Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989;86:282-288.
24. Rauch F, Travers R, Norman ME, Taylor A, Parfitt AM, Glorieux FH: The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone 2002;31:85-89.
25. Krause U, Harris S, Green A, Ylostalo J, Zeitouni S, Lee N, Gregory CA: Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci USA 2010;107:4147-4152.
26. Long MW: Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis 2001;27:677-690.
27. Rasmussen TP: Embryonic stem cell differentiation: a chromatin perspective. Reprod Biol Endocrinol 2003;1:100.
28. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 1997;89:747-754.
29. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M: Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999;274:6972-6978.
30. Karsenty G: Role of Cbfa1 in osteoblast differentiation and function. Semin Cell Dev Biol 2000;11:343-346.
31. Ichida F, Nishimura R, Hata K, Matsubara T, Ikeda F, Hisada K, Yatani H, Cao X, Komori T, Yamaguchi A, Yoneda T: Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J Biol Chem 2004;279:34015-34022.
32. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H: PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846-855.
33. Takada I, Suzawa M, Matsumoto K, Kato S: Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 2007;1116:182-195.
34. Lecanda F, Towler DA, Ziambaras K, Cheng SL, Koval M, Steinberg TH, Civitelli R: Gap junctional communication modulates gene expression in oste-oblastic cells. Mol Biol Cell 1998;9:2249-2258. (Pubitemid 28373637)
35. Li Z, Zhou Z, Yellowley CE, Donahue HJ: Inhibiting gap junctional intercellular communication alters expression of differentiation markers in osteoblastic cells. Bone 1999;25:661-666.